Developer docs
API playgroundTry for free, no card

Search company profiles

Clearview Capital

Full company profile

uuid0000pkh

Namestring
Clearview Capital
Legal namestring
Clearview Capital
Company typeenum
Private
Founded yearint
1999
Descriptiontext

Clearview Capital is a Stamford, Connecticut-based private equity firm founded in 2010 that specializes in the acquisition and recapitalization of North American companies generating $3-15 million of operating profit. The firm operates with a lean team of 11-50 employees led by founder James Andersen, managing partners Calvin Neider and Matthew W Blevins, and managing directors James Waddoups and Kyle Eklund. Clearview runs an acquisition-led growth strategy, deploying committed capital to build platform companies that subsequently pursue add-on roll-ups; its $550 million committed fund launched Capitol Imaging roughly seven years ago, growing that imaging platform from 20 to 48 locations across Texas, Louisiana, Alabama, Mississippi, and Florida.

The firm's portfolio spans at least nine disclosed platforms across multiple verticals: healthcare imaging (Capitol Imaging), behavioral health (Advantage Behavioral Health, Community Medical Services), marketing services (UpSwell, Taradel), outdoor recreation (Worldwide Camping Holdings), and industrial/niche markets (Nielsen-Kellerman, Wilson Orchard & Vineyard Supply, Controlled Products, Advanced Medical Personnel Services, Xact Data Discovery, Twinco Romax). Clearview's revenue model is conventional for a lower-middle-market PE firm, generating income through management fees on committed capital and carried interest on realizations rather than selling products or services to end customers. Recent 2025 activity (Capitol Imaging's DRH & Associates deal, UpSwell's Taradel acquisition, and the Advantage Behavioral Health recapitalization) indicates active ongoing deployment and a repeatable playbook of platform-building through fragmented-market consolidation.

Short descriptiontext

Clearview Capital is a Stamford, Connecticut-based private equity firm founded in 2010 that acquires and recapitalizes North American companies with $3-15 million of operating profit, building diversified platform companies across healthcare, marketing, and industrial verticals via acquisition-led growth.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersStamford, United States
HQ citystring
Stamford
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
private equity investing, middle market acquisitions, company recapitalization, portfolio company management, acquisition-led growth
Industry1 code
PRIMARYFSANADAJ
Large-Cap / Sponsor Finance Direct Lending
Financial & Insurance/Private Equity & Venture Capital/Private Credit / Direct Lending Funds
NAICS code1 code
  • Other Financial Vehicles52599
SIC code1 code
  • Investors, Nec6799
Product category
Private Equity Investment Management
Social media profiles2 records
Cost components3 values
Personnel, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Clearview Capital is a private equity firm that acquires and recapitalizes North American companies with operating profits of $3–15 million. The firm deploys committed capital through its $550 million fund to support acquisition-led growth strategies within its portfolio companies across healthcare, marketing, and business services sectors.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Private Equity Fund Management
Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Lower-middle market private equity firm focused on acquiring and recapitalizing North American companies with similar EBITDA profiles. Both firms pursue control investments in healthcare, business services, and consumer verticals with comparable check sizes and operating profit targets.

TypeDirect peer
Description

Lower-middle market PE firm targeting companies typically with $5-50M of EBITDA across business services, healthcare, and technology. Comparable to Clearview in fund size, deal structure, and acquisition-led growth strategy with portfolio company add-ons.

TypeDirect peer
Description

Lower-middle market private equity firm focused on founder-owned businesses and corporate carve-outs in healthcare services, business services, and consumer. Directly comparable in target company profile, hold period, and value-creation playbook.

TypeDirect peer
Description

Lower-middle market PE firm investing in companies with $5-50M revenue across business services, healthcare, and industrial sectors. Highly comparable operating-partner model and acquisition-led growth strategy targeting similar EBITDA range.

TypeDirect peer
Description

Healthcare-focused lower-middle market PE firm backing companies with $5-50M EBITDA. Closely comparable given Clearview's significant healthcare deployment through Capitol Imaging and Advantage Behavioral Health.

TypeDirect peer
Description

Private equity firm focused on lower-middle market consumer, business services, and healthcare companies. Comparable investment thesis, fund size, and acquisition-led platform-building approach to Clearview's strategy.

TypeDirect peer
Description

Lower-middle market PE firm partnering with management teams of companies with $3-15M of EBITDA. Directly comparable given near-identical EBITDA target range and similar vertical focus on healthcare and business services.

TypeDirect peer
Description

Growth-oriented private equity firm investing in lower-middle market companies, often founder-led. Comparable in check size and operating company focus, with overlapping verticals in business services and healthcare.

TypeDirect peer
Description

Lower-middle market PE firm focused on control investments in North American companies with $5-50M EBITDA. Directly comparable fund size, deal structure, and operating-partner approach to value creation.

TypeEmerging player
Description

Lower-middle market PE firm focused on technology-enabled business services and healthcare companies. Comparable deal size and vertical mix, with slightly different sub-sector emphasis but overlapping investment philosophy.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks1 record

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries5 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A9 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment6 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Clearview Capital

Private Equity Investment Managementclearviewcap.com

Clearview Capital is a Stamford, Connecticut-based private equity firm founded in 2010 that acquires and recapitalizes North American companies with $3-15 million of operating profit, building diversified platform companies across healthcare, marketing, and industrial verticals via acquisition-led growth.

What Clearview Capital does

Clearview Capital is a Stamford, Connecticut-based private equity firm founded in 2010 that specializes in the acquisition and recapitalization of North American companies generating $3-15 million of operating profit. The firm operates with a lean team of 11-50 employees led by founder James Andersen, managing partners Calvin Neider and Matthew W Blevins, and managing directors James Waddoups and Kyle Eklund. Clearview runs an acquisition-led growth strategy, deploying committed capital to build platform companies that subsequently pursue add-on roll-ups; its $550 million committed fund launched Capitol Imaging roughly seven years ago, growing that imaging platform from 20 to 48 locations across Texas, Louisiana, Alabama, Mississippi, and Florida.

The firm's portfolio spans at least nine disclosed platforms across multiple verticals: healthcare imaging (Capitol Imaging), behavioral health (Advantage Behavioral Health, Community Medical Services), marketing services (UpSwell, Taradel), outdoor recreation (Worldwide Camping Holdings), and industrial/niche markets (Nielsen-Kellerman, Wilson Orchard & Vineyard Supply, Controlled Products, Advanced Medical Personnel Services, Xact Data Discovery, Twinco Romax). Clearview's revenue model is conventional for a lower-middle-market PE firm, generating income through management fees on committed capital and carried interest on realizations rather than selling products or services to end customers. Recent 2025 activity (Capitol Imaging's DRH & Associates deal, UpSwell's Taradel acquisition, and the Advantage Behavioral Health recapitalization) indicates active ongoing deployment and a repeatable playbook of platform-building through fragmented-market consolidation.

Clearview Capital firmographics

Firmographics
Name
Clearview Capital
Legal name
Clearview Capital
Website
https://clearviewcap.com
Company type
Private
Founded year
1999
Operating status
Operating
Headcount range
11–50 employees
Short description
Clearview Capital is a Stamford, Connecticut-based private equity firm founded in 2010 that acquires and recapitalizes North American companies with $3-15 million of operating profit, building diversified platform companies across healthcare, marketing, and industrial verticals via acquisition-led growth.
Ownership category
akta.pro rank

Clearview Capital industry classification

Industry
Product category
Private Equity Investment Management
NAICS
Other Financial Vehicles (52599)
SIC
Investors, Nec (6799)
akta.pro industry
PRIMARYFSANADAJ
Large-Cap / Sponsor Finance Direct Lending
Financial & Insurance/Private Equity & Venture Capital/Private Credit / Direct Lending Funds

Keywords

  • Private equity investing
  • Middle market acquisitions
  • Company recapitalization
  • Portfolio company management
  • Acquisition-led growth

Where Clearview Capital is headquartered

Location

Headquarters

HQ city
Stamford
HQ country
United States
HQ region
North America

Markets served

Clearview Capital business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales

Clearview Capital product offering

Product offering

Core offering

Clearview Capital is a private equity firm that acquires and recapitalizes North American companies with operating profits of $3–15 million. The firm deploys committed capital through its $550 million fund to support acquisition-led growth strategies within its portfolio companies across healthcare, marketing, and business services sectors.

Differentiator

Problem solved

Functional benefit

Products and services

  • Private Equity Fund Management

Companies that use Clearview Capital

Customer profile

Segments1 record

Ideal customer profiles1 record

Clearview Capital technology and API

Technology

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Clearview Capital partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves6 records

Expansion highlights4 records

Clearview Capital competitors and assessment

Company assessment

Direct peers

  • Centre Partners: Lower-middle market private equity firm focused on acquiring and recapitalizing North American companies with similar EBITDA profiles. Both firms pursue control investments in healthcare, business services, and consumer verticals with comparable check sizes and operating profit targets.
  • LLR Partners: Lower-middle market PE firm targeting companies typically with $5-50M of EBITDA across business services, healthcare, and technology. Comparable to Clearview in fund size, deal structure, and acquisition-led growth strategy with portfolio company add-ons.
  • Trinity Hunt Partners: Lower-middle market private equity firm focused on founder-owned businesses and corporate carve-outs in healthcare services, business services, and consumer. Directly comparable in target company profile, hold period, and value-creation playbook.
  • Huron Capital: Lower-middle market PE firm investing in companies with $5-50M revenue across business services, healthcare, and industrial sectors. Highly comparable operating-partner model and acquisition-led growth strategy targeting similar EBITDA range.
  • Sheridan Capital Partners: Healthcare-focused lower-middle market PE firm backing companies with $5-50M EBITDA. Closely comparable given Clearview's significant healthcare deployment through Capitol Imaging and Advantage Behavioral Health.
  • Argonne Capital Group: Private equity firm focused on lower-middle market consumer, business services, and healthcare companies. Comparable investment thesis, fund size, and acquisition-led platform-building approach to Clearview's strategy.
  • Plexus Capital: Lower-middle market PE firm partnering with management teams of companies with $3-15M of EBITDA. Directly comparable given near-identical EBITDA target range and similar vertical focus on healthcare and business services.
  • Mainsail Partners: Growth-oriented private equity firm investing in lower-middle market companies, often founder-led. Comparable in check size and operating company focus, with overlapping verticals in business services and healthcare.
  • High Road Capital Partners: Lower-middle market PE firm focused on control investments in North American companies with $5-50M EBITDA. Directly comparable fund size, deal structure, and operating-partner approach to value creation.

Emerging players

  • Periscope Equity: Lower-middle market PE firm focused on technology-enabled business services and healthcare companies. Comparable deal size and vertical mix, with slightly different sub-sector emphasis but overlapping investment philosophy.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks1 record

Key highlights6 records

Customer concentration

Clearview Capital social profiles

Digital presence

Clearview Capital financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Clearview Capital leadership team

Management profile

Number of profiles

Profiles6 records

Clearview Capital subsidiaries and ownership

Company hierarchy

Subsidiaries5 records

Clearview Capital funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Clearview Capital M&A and investment

M&A and investment

M&A9 records

Investments6 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Clearview Capital

What does Clearview Capital do?

Clearview Capital is a private equity firm that acquires and recapitalizes North American companies with operating profits of $3–15 million. The firm deploys committed capital through its $550 million fund to support acquisition-led growth strategies within its portfolio companies across healthcare, marketing, and business services sectors.

Is Clearview Capital a public or private company?

Clearview Capital is a private company. It is currently operating.

When was Clearview Capital founded?

Clearview Capital was founded in 1999. It employs 11 to 50 people.

Where is Clearview Capital based?

Clearview Capital is headquartered in Stamford, United States, in the North America region.

Who are Clearview Capital's main competitors?

Direct peers on record are Centre Partners, LLR Partners, Trinity Hunt Partners, Huron Capital, Sheridan Capital Partners, Argonne Capital Group, Plexus Capital, Mainsail Partners and High Road Capital Partners. Periscope Equity is listed as an emerging player.

Does Clearview Capital have an API?

No public API is recorded for Clearview Capital.

What industry is Clearview Capital in?

Clearview Capital's product category is Private Equity Investment Management. Its primary akta.pro industry code is FSANADAJ, Large-Cap / Sponsor Finance Direct Lending. Its NAICS code is 52599 and its SIC code is 6799.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
citybizLJM Partners With Clearview Capital to Expand Parcel Shipping Technology PlatformLJM Partners has partnered with Clearview Capital in a transaction closed on May 6, 2026, to secure capital for expanding its parcel shipping technology and advisory services. LJM plans to direct these resources toward enhancing its Parcel Intelligence Platform and executive shipping advisory offerings as businesses face increasing complexity in carrier pricing from providers like UPS and FedEx.AijournLJM Partners with Clearview Capital to Accelerate Next Phase of GrowthLJM announced a strategic partnership with private investment firm Clearview Capital to accelerate its growth and enhance its technology and analytics capabilities. The transaction, which closed in May 2026, provides resources for LJM to expand its Parcel Intelligence Platform and executive shipping advisory services amidst rising parcel costs driven by carriers like UPS and FedEx.Third NewsLJM Partners with Clearview Capital to Enhance Shipping SolutionsLJM Partners, a technology-enabled parcel shipping advisory firm, has entered into a strategic partnership with private investment firm Clearview Capital to enhance its technological capabilities and expand its operations. The collaboration, finalized on May 6, 2026, will provide LJM with resources to invest in its Parcel Intelligence Platform and analytics services to help clients optimize shipping costs amidst rising carrier fees. This move positions LJM to scale its advisory services while maintaining its existing high-touch service model for its client base.PR NewswireLJM Partners with Clearview Capital to Accelerate Next Phase of GrowthLJM announced a partnership with Clearview Capital, closing May 6, 2026, to fund growth in its parcel shipping advisory services. The investment will support its Parcel Intelligence Platform and analytics, with LJM serving over 1,500 businesses and processing 5.5 billion parcels.PrivateequitywireClearview Capital exits behavioural healthcare platform through $610m muni bond-backed salePrivate equity firm Clearview Capital has agreed to exit US behavioural healthcare provider Advantage Behavioral Health through a sale to nonprofit organization QCF/I, Inc., financed by a planned $610 million non-rated municipal bond issuance, with Clearview and ABH's founders set to receive approximately $415 million at closing plus up to $100 million in potential earnout. The transaction has attracted scrutiny from municipal bond investors who have questioned the level of leverage and the relatively limited real estate backing, with only around $14.4 million of ABH's valuation represented by owned property. The business is expected to generate around $78 million of EBITDA this year, projected to rise to $90.8 million by 2027, as KeyBanc Capital Markets works on around $3 billion in comparable healthcare transactions.BloombergPrivate Equity Firm Unloads Mental Health Chain Into Muni Market - BloombergClearview Capital, a Connecticut-based private equity firm, is selling Advantage Behavioral Health, a New Jersey-based chain of mental health centers and sober-living homes, through a municipal bond-financed transaction. The sale comes just over a year after Clearview recapitalized the company in partnership with its founders and management. The deal represents a common exit strategy for PE firms seeking to monetize healthcare assets through the municipal debt market.LevinassociatesClearview Capital Sells Advantage Behavioral Health to QCF/IQCF/I agreed to acquire Advantage Behavioral Health and Wellness from Clearview Capital, financing the deal with a New Jersey Economic Development Authority conduit bond not to exceed $653.4 million. Advantage, an outpatient mental health provider, services over 500,000 annual patient visits across nine states. The acquisition marks QCF/I's first deal of 2025.BhbusinessAdvantage Behavioral Health Set to Be Acquired by Nonprofit EntityQCF/I, Inc., a Georgia-based nonprofit that owns and operates addiction treatment and mental health facilities, is acquiring Laurel Springs, New Jersey-based Advantage Behavioral Health and Wellness in a deal financed through a NJEDA conduit bond of up to $653.4 million. The NJEDA board unanimously approved the transaction, which includes Advantage Behavioral Health's 48 New Jersey locations plus facilities across California, Florida, Indiana, Ohio, Maryland, Massachusetts, and Pennsylvania. Private equity firm Clearview Capital, which invested in Advantage Behavioral Health in April 2025, is expected to exit after approximately one year, with the final bond issuance closing scheduled for July 30, 2026.BhbusinessAdvantage Behavioral Health Gets Boost from PE Firm Clearview Capital to Accelerate GrowthClearview Capital invested in outpatient behavioral health provider Advantage Behavioral Health, closing a recapitalization deal on April 1. Terms were not disclosed, but the company operates 21 locations and conducts about 500,000 patient visits annually. CEO Colin Studwell said the deal will accelerate growth.PR NewswireJEGI CLARITY Has Advised Taradel on Their Sale to UpSwell, a Portfolio Company of Clearview CapitalTaradel, advised by JEGI CLARITY, was sold to UpSwell, a Clearview Capital portfolio company. UpSwell will integrate Taradel's self-service direct mail and digital marketing platform to offer comprehensive marketing services. The acquisition strengthens UpSwell's ability to deliver both self-service and expert-guided marketing solutions.